Long-Term Outcomes of Extracorporeal Life Support in Respiratory Failure
Open Access
- 9 August 2023
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (16) , 5196
Abstract
Although extracorporeal life support is an expensive method with serious risks of complications, it is nowadays a well-established and generally accepted method of organ support. In patients with severe respiratory failure, when conventional mechanical ventilation cannot ensure adequate blood gas exchange, veno-venous extracorporeal membrane oxygenation (ECMO) is the method of choice. An improvement in oxygenation or normalization of acid–base balance by itself does not necessarily mean an improvement in the outcome but allows us to prevent potential negative effects of mechanical ventilation, which can be considered a crucial part of complex care leading potentially to an improvement in the outcome. The disconnection from ECMO or discharge from the intensive care unit should not be viewed as the main goal, and the long-term outcome of the ECMO-surviving patients should also be considered. Approximately three-quarters of patients survive the veno-venous ECMO, but various (both physical and psychological) health problems may persist. Despite these, a large proportion of these patients are eventually able to return to everyday life with relatively little limitation of respiratory function. In this review, we summarize the available knowledge on long-term mortality and quality of life of ECMO patients with respiratory failure.Keywords
Funding Information
- Ministry of Health, Czech Republic—conceptual development of research organization (FNOs/2022)
This publication has 48 references indexed in Scilit:
- Long-Term Cognitive Impairment after Critical IllnessNew England Journal of Medicine, 2013
- The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndromeIntensive Care Medicine, 2013
- Radiologic Outcomes at 5 Years After Severe ARDSChest, 2013
- Long-term quality of life in patients with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation for refractory hypoxaemiaCritical Care, 2012
- Long-term Outcomes of Pandemic 2009 Influenza A(H1N1)-Associated Severe ARDSChest, 2012
- Quality of Life, Pulmonary Function, and Tomographic Scan Abnormalities After ARDSChest, 2011
- Functional Disability 5 Years after Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2011
- Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trialThe Lancet, 2009
- ECMO in ARDS: a long‐term follow‐up study regarding pulmonary morphology and function and health‐related quality of lifeActa Anaesthesiologica Scandinavica, 2009
- Pulmonary Function and Health-related Quality of Life in Survivors of Acute Respiratory Distress SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2003